Corrigendum to "Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia" [Eur. J. Med. Chem. 238 (2022) 114479]

Affiliations

• ¹ Jiangsu Key Laboratory of Drug Design and Optimization, Department of Chemistry, China Pharmaceutical University, Nanjing, 211198, China.
• ² Jiangsu Key Laboratory of Drug Design and Optimization, Department of Chemistry, China Pharmaceutical University, Nanjing, 211198, China. Electronic address: zxj@cpu.edu.cn.